HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of antenatal zinc supplementation on impetigo in infants in Bangladesh.

Abstract
We sought to determine the effects of maternal zinc supplementation on skin infections among infants in poor urban areas of Dhaka, Bangladesh. A double-blind, placebo-controlled, randomized trial was conducted among 199 and 221 Bangladeshi infants whose mothers were administered 30 mg daily of zinc or placebo, respectively. The mothers received zinc supplementation from 12-16 weeks' gestation until delivery, and the infants were followed up until 6 months of age. Among the infants of mothers who received zinc supplementation during the antenatal period, 10.6% had at least 1 episode of impetigo compared with 19.6% of the infants of mothers in the placebo group (P = 0.01). Infants in the treatment group had a 54% reduction in incidence rate of episodes of impetigo when compared with infants in the placebo group (P = 0.01). The effect of zinc supplementation was more pronounced among male infants (64% reduction) and intrauterine growth restricted and low birth weight infants (73% reduction) and among infants of mothers with increased parity (60% reduction) or decreased socioeconomic status (71% reduction).
AuthorsGary L Darmstadt, Saskia J M Osendarp, Saifuddin Ahmed, Candace Feldman, Joop M A Van Raaij, Abdullah H Baqui, J G A J Hautvast, George J Fuchs
JournalThe Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 31 Issue 4 Pg. 407-9 (Apr 2012) ISSN: 1532-0987 [Electronic] United States
PMID22189527 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Placebos
  • Zinc
Topics
  • Adult
  • Bangladesh (epidemiology)
  • Diet (methods)
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Humans
  • Impetigo (epidemiology, prevention & control)
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Placebos (administration & dosage)
  • Pregnancy
  • Zinc (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: